| scholarly article | Q13442814 |
| editorial | Q871232 |
| P6179 | Dimensions Publication ID | 1000439657 |
| P356 | DOI | 10.1245/S10434-010-1362-Z |
| P953 | full work available at URL | https://link.springer.com/content/pdf/10.1245/s10434-010-1362-z.pdf |
| http://link.springer.com/content/pdf/10.1245/s10434-010-1362-z.pdf | ||
| http://www.annalssurgicaloncology.org/cgi/content/abstract/17/12/3077 | ||
| http://link.springer.com/article/10.1245/s10434-010-1362-z/fulltext.html | ||
| http://link.springer.com/content/pdf/10.1245/s10434-010-1362-z | ||
| P698 | PubMed publication ID | 20882416 |
| P5875 | ResearchGate publication ID | 46821538 |
| P2093 | author name string | Kay Washington | |
| P2860 | cites work | The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis | Q31518944 |
| Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. | Q40455670 | ||
| Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma | Q40559629 | ||
| Worldwide esophageal cancer collaboration | Q44185301 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3077-3079 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | 7th Edition of the AJCC Cancer Staging Manual: Stomach | |
| P478 | volume | 17 |
| Q55619557 | 12-Lipoxygenase promotes invasion and metastasis of human gastric cancer cells via epithelial-mesenchymal transition. |
| Q35919191 | 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer |
| Q97526924 | A 3-MicroRNA Signature Identified From Serum Predicts Clinical Outcome of the Locally Advanced Gastric Cancer |
| Q33854972 | A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study |
| Q35953753 | A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems. |
| Q37427978 | A Novel Prognostic Score, Based on Preoperative Nutritional Status, Predicts Outcomes of Patients after Curative Resection for Gastric Cancer |
| Q88598870 | A Propensity Score-Matched Comparison of Robotic Versus Laparoscopic Gastrectomy for Gastric Cancer: Oncological, Cost, and Surgical Stress Analysis |
| Q89861887 | A SOX2 Reporter System Identifies Gastric Cancer Stem-Like Cells Sensitive to Monensin |
| Q55645958 | A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching. |
| Q36085663 | A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients |
| Q33897382 | A modified delta-shaped gastroduodenostomy in totally laparoscopic distal gastrectomy for gastric cancer: a safe and feasible technique |
| Q64119221 | A multi-center prospective randomized controlled trial (phase III) comparing the quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric Cancer (study protocol) |
| Q37687822 | A new predictive model combined of tumor size, lymph nodes count and lymphovascular invasion for survival prognosis in patients with lymph node-negative gastric cancer |
| Q37433049 | A nomogram for predicting the likelihood of lymph node metastasis in early gastric signet ring cell carcinoma: A single center retrospective analysis with external validation |
| Q37076812 | A non-progressive signet patient with ring cell gastric adenocarcinoma who survived for 6 years without treatment |
| Q50052974 | A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4). |
| Q37204604 | A polymorphism at the microRNA binding site in the 3'-untranslated region of C14orf101 is associated with the risk of gastric cancer development |
| Q52986198 | A preoperatively predictive difficulty scoring system for laparoscopic spleen-preserving splenic hilar lymph node dissection for gastric cancer: experience from a large-scale single center. |
| Q42366606 | A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort |
| Q58790965 | AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients |
| Q35078072 | ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status |
| Q47403917 | Aberrant expression of PlncRNA-1 and TUG1: potential biomarkers for gastric cancer diagnosis and clinically monitoring cancer progression |
| Q35147072 | Abnormal FHIT protein expression may be correlated with poor prognosis in gastric cancer: a meta-analysis |
| Q44245903 | Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival |
| Q35152328 | Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer |
| Q64105847 | Actual compliance to adjuvant chemotherapy in gastric cancer |
| Q33691272 | Adenocarcinoma of the duodenojejunal flexure presenting as a stricturous lesion |
| Q53342022 | Adjuvant Therapy Completion Rates in Patients with Gastric Cancer Undergoing Perioperative Chemotherapy Versus a Surgery-First Approach. |
| Q38364619 | Adjuvant and neoadjuvant options in resectable gastric cancer: is there an optimal treatment approach? |
| Q41622262 | Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction |
| Q26774528 | Advanced gastric cancer: What we know and what we still have to learn |
| Q64962997 | Advanced gastric cancer: the value of surgery. |
| Q90318996 | Advancements and challenges in treating advanced gastric cancer in the West |
| Q40894524 | Aging over 70 Years Is Not a Decisively Dismal Prognostic Factor in Gastric Cancer Surgery |
| Q37152525 | Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancer |
| Q36375355 | Alterations in vitamin D signaling pathway in gastric cancer progression: a study of vitamin D receptor expression in human normal, premalignant, and malignant gastric tissue |
| Q90744374 | Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer |
| Q52733772 | Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients. |
| Q49926075 | Anatomical location of metastatic lymph nodes: an indispensable prognostic factor for gastric cancer patients who underwent curative resection |
| Q95360001 | Anatomical variation of infra-pyloric artery origination: A prospective multicenter observational study (IPA-Origin) |
| Q35865270 | Anatomy and influence of the splenic artery in laparoscopic spleen-preserving splenic lymphadenectomy |
| Q54969912 | Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations. |
| Q37549211 | Anthropometric Study of the Stomach |
| Q36035480 | Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocol |
| Q42149763 | Association between CXCR2 and IL-22BP expression indicate a poor outcome for gastric adenocarcinoma progression |
| Q60956827 | Association between Polymorphisms in Inflammatory Response-Related Genes and the Susceptibility, Progression and Prognosis of the Diffuse Histological Subtype of Gastric Cancer |
| Q37610189 | Association between genetic variants in the XPG gene and gastric cancer risk in a Southern Chinese population |
| Q41729920 | Association between polymorphisms of microRNA-binding sites in integrin genes and gastric cancer in Chinese Han population |
| Q47095591 | Association between spectral computed tomography images and clinicopathological features in advanced gastric adenocarcinoma |
| Q38766702 | Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer |
| Q47271008 | Association of O6-Methylguanine-DNA Methyltransferase Protein Expression With Postoperative Prognosis and Adjuvant Chemotherapeutic Benefits Among Patients With Stage II or III Gastric Cancer |
| Q39099739 | Association of interleukin 22 polymorphisms with gastric cancer risk |
| Q35057690 | Associations of genetic variants in the PSCA, MUC1 and PLCE1 genes with stomach cancer susceptibility in a Chinese population |
| Q39127080 | BAY 11-7082, a nuclear factor-κB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells |
| Q51386691 | BMP8B Is a Tumor Suppressor Gene Regulated by Histone Acetylation in Gastric Cancer. |
| Q47162575 | Beclin-1 suppresses gastric cancer progression by promoting apoptosis and reducing cell migration |
| Q38958977 | Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms |
| Q53074070 | Body mass index and mortality in patients with gastric cancer: a large cohort study. |
| Q36354042 | Bursectomy and non-bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China |
| Q89475533 | C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer |
| Q37709018 | C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA. |
| Q33679729 | CARP is a potential tumor suppressor in gastric carcinoma and a single-nucleotide polymorphism in CARP gene might increase the risk of gastric carcinoma |
| Q53210821 | CDKN1A histone acetylation and gene expression relationship in gastric adenocarcinomas. |
| Q87257621 | CEA/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinoma |
| Q64080759 | CONVERSION THERAPY FOR GASTRIC CANCER: EXPANDING THE TREATMENT POSSIBILITIES |
| Q58095171 | CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial |
| Q52649581 | CT volumetry for gastric adenocarcinoma: association with lymphovascular invasion and T-stages. |
| Q41691651 | CT/MRI accuracy in detecting and determining preoperative stage of gastric adenocarcinoma in Albania |
| Q36085855 | CXCL1 expression is correlated with Snail expression and affects the prognosis of patients with gastric cancer |
| Q90278559 | Caveolin‑1 enhances RANKL‑induced gastric cancer cell migration |
| Q37382630 | Changes of quality of life after gastric tube reconstruction in adenocarcinoma of the esophagogastric junction |
| Q39449701 | Changing Trends in Stomach Cancer Throughout the World. |
| Q55425747 | Characteristics and survival outcomes related to the infra-pyloric lymph node status of gastric cancer patients. |
| Q64906335 | Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer. |
| Q33618527 | Circular RNAs signature predicts the early recurrence of stage III gastric cancer after radical surgery. |
| Q88878990 | Clinical Evaluation of Serum Tumor Markers in the Diagnosis of Gastric Adenocarcinoma Staging and Grading |
| Q89761196 | Clinical Pathways for Oncological Gastrectomy: Are They a Suitable Instrument for Process Standardization to Improve Process and Outcome Quality for Patients Undergoing Gastrectomy? A Retrospective Cohort Study |
| Q35834449 | Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy |
| Q94545799 | Clinical and prognostic association of oncogene cadherin 11 in gastric cancer |
| Q44788875 | Clinical and prognostic implications of β1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer |
| Q35059969 | Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy |
| Q40467151 | Clinical features of postoperative anastomotic bleeding after gastrectomy and efficacy of endoscopic hemostasis: a case-control study. |
| Q37613953 | Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer |
| Q51103019 | Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma. |
| Q37711697 | Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer |
| Q36572148 | Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients. |
| Q36648866 | Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer |
| Q26828549 | Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis |
| Q53536917 | Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases. |
| Q35716215 | Clinicopathologic and molecular features associated with patient age in gastric cancer |
| Q36330176 | Clinicopathologic implication of meticulous pathologic examination of regional lymph nodes in gastric cancer patients |
| Q90396610 | Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series |
| Q37104749 | Clinicopathological Characteristics, Treatment, and Prognosis of 21 Patients with Primary Gastric Squamous Cell Carcinoma |
| Q30050395 | Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach |
| Q35321267 | Clinicopathological characteristics, diagnosis, treatment, and outcomes of primary gastric adenosquamous carcinoma |
| Q36936790 | Clinicopathological significance of platelet-derived growth factor B, platelet-derived growth factor receptor-β, and E-cadherin expression in gastric carcinoma |
| Q57797913 | Clockwise, Modularized Lymphadenectomy in Laparoscopic Gastric Cancer Surgery: a New Laparoscopic Surgery Model |
| Q50321036 | Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer |
| Q37376581 | Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection |
| Q38714610 | Comparative study between endoscopic submucosal dissection and surgery in patients with early gastric cancer. |
| Q64248865 | Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer |
| Q34036711 | Comparision of modified and conventional delta-shaped gastroduodenostomy in totally laparoscopic surgery |
| Q37605406 | Comparison between superficial muscularis propria and deep muscularis propria infiltration in gastric cancer patients: A retrospective cohort study |
| Q41921004 | Comparison of MRI and endoscope ultrasound detection in preoperative T/N staging of gastric cancer |
| Q38710975 | Comparison of Oral Contrast-Enhanced Transabdominal Ultrasound Imaging With Transverse Contrast-Enhanced Computed Tomography in Preoperative Tumor Staging of Advanced Gastric Carcinoma. |
| Q26771422 | Comparison of Prognostic MicroRNA Biomarkers in Blood and Tissues for Gastric Cancer |
| Q47755937 | Comparison of Young Patients with Gastric Cancer in the United States and China |
| Q57453810 | Comparison of gastric cancer survival after R0 resection in the US and China |
| Q37205149 | Comparison of laparoscopy-assisted and open radical gastrectomy for advanced gastric cancer: A retrospective study in a single minimally invasive surgery center |
| Q89184044 | Comparison of short-term and long-term efficacy of laparoscopic and open gastrectomy in high-risk patients with gastric cancer: a propensity score-matching analysis |
| Q33927566 | Comparison of short-term postoperative outcomes in totally laparoscopic distal gastrectomy versus laparoscopy-assisted distal gastrectomy |
| Q43838830 | Comparison of survival and prognostic factors in patients with gastric adenocarcinoma in T2 and T3. |
| Q37411029 | Comparison of survival of surgical resection and conservative treatment in patients with gastric cancer aged 80 years or older: a single-center experience |
| Q35856796 | Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the "N" parameter-related survival: the monoinstitutional NodUs Italian study. |
| Q42366479 | Comparison of the Differences in Survival Rates between the 7th and 8th Editions of the AJCC TNM Staging System for Gastric Adenocarcinoma: a Single-Institution Study of 5,507 Patients in Korea |
| Q82100942 | Completely laparoscopic versus open gastrectomy for early and advanced gastric cancer: a matched cohort study |
| Q50215058 | Comprehensive Analysis of the Neutrophil-to-Lymphocyte Ratio for Preoperative Prognostic Prediction Nomogram in Gastric Cancer |
| Q57070177 | Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study |
| Q47099962 | Consideration of clinicopathologic features improves patient stratification for multimodal treatment of gastric cancer. |
| Q91817451 | Contribution of DECT in detecting serosal invasion of gastric cancer |
| Q90221696 | Conversion therapy for advanced gastric cancer with trastuzumab combined with chemotherapy: A case report |
| Q38702622 | Correlation between preoperative endoscopic ultrasound and surgical pathology staging of gastric adenocarcinoma: A single institution retrospective review |
| Q53216791 | Correlations of fascin-1 and cadherin-17 protein expression with clinicopathologic features and prognosis of patients with gastric cancer. |
| Q54998096 | Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer? |
| Q26801289 | Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers |
| Q38933553 | Current Perspectives on Gastric Cancer |
| Q38414905 | Current status and scope of lymph node micrometastasis in gastric cancer. |
| Q41613126 | Current status of lymph node micrometastasis in gastric cancer |
| Q55258604 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience. |
| Q52605589 | Daikenchuto for reducing postoperative ileus in patients undergoing elective abdominal surgery. |
| Q37020109 | Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer |
| Q41298273 | Decreased expression of granulocyte-macrophage colony-stimulating factor is associated with adverse clinical outcome in patients with gastric cancer undergoing gastrectomy |
| Q34121330 | Decreased intratumoral Foxp3 Tregs and increased dendritic cell density by neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer |
| Q35804400 | Deregulated Expression of SRC, LYN and CKB Kinases by DNA Methylation and Its Potential Role in Gastric Cancer Invasiveness and Metastasis |
| Q34141405 | Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer |
| Q36334837 | Detection of gastric cancer using transabdominal ultrasonography is associated with tumor diameter and depth of invasion |
| Q87035821 | Detection of perioperative cancer antigen 72-4 in gastric juice pre- and post-distal gastrectomy and its significances |
| Q39079745 | Detection value of free cancer cells in peritoneal washing in gastric cancer: a systematic review and meta-analysis |
| Q53199216 | Diagnostic performance of 64-section CT using CT gastrography in preoperative T staging of gastric cancer according to 7th edition of AJCC cancer staging manual. |
| Q92713132 | Diagnostic value of negative enrichment and immune fluorescence in situ hybridization for intraperitoneal free cancer cells of gastric cancer |
| Q39127919 | Differences in the multimodal treatment of gastric cancer: East versus west |
| Q61447505 | Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis |
| Q39011776 | Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A. |
| Q91756279 | Differential gene expression in growth factors, epithelial mesenchymal transition and chemotaxis in the diffuse type compared with the intestinal type of gastric cancer |
| Q53652240 | Differential role of Wnt signaling and base excision repair pathways in gastric adenocarcinoma aggressiveness. |
| Q37001771 | Diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion of gastrointestinal cancers |
| Q37626654 | Distal gastrectomy versus total gastrectomy for distal gastric cancer |
| Q55117181 | Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology. |
| Q41111911 | Do All Patients Require Prophylactic Drainage After Gastrectomy for Gastric Cancer? The Experience of a High-Volume Center |
| Q64108454 | Does Lymphadenectomy with at Least 15 Perigastric Lymph Nodes Retrieval Promise an Improved Survival for Gastric Cancer: A Retrospective Cohort Study in Southern China |
| Q37606061 | Does the interval of screening endoscopy affect survival in gastric cancer patients?: A cross-sectional study |
| Q33864093 | Does tumor size improve the accuracy of prognostic predictions in node-negative gastric cancer (pT1-4aN0M0 stage)? |
| Q92335758 | Down-regulation of circular RNA ITCH and circHIPK3 in gastric cancer tissues |
| Q39245971 | Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer |
| Q38232035 | Dynamic contrast-enhanced MRI of gastric cancer: Correlation of the perfusion parameters with pathological prognostic factors |
| Q41506637 | Dysphagia is not a Valuable Indicator of Tumor Response after Preoperative Chemotherapy for R0 Resected Patients with Adenocarcinoma of the Gastroesophageal Junction |
| Q28538710 | EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model? |
| Q47105249 | ERCC1 rs3212986 A/C polymorphism is not associated with chemotherapy treatment outcomes in gastric cancer patients: evidence from 11 publications in Chinese populations |
| Q41390145 | Early postoperative tumor marker responses provide a robust prognostic indicator for N3 stage gastric cancer |
| Q43641129 | Early results of a modified splenic hilar lymphadenectomy in laparoscopy-assisted total gastrectomy for gastric cancer with stage cT1-2: a case-control study |
| Q41878340 | Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients |
| Q33829754 | Effect of M1a and M1b category in metastatic colorectal cancer |
| Q50961972 | Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high-incidence region of Korea. |
| Q55646180 | Effect of the degree of gastric filling on the measured thickness of advanced gastric cancer by computed tomography. |
| Q90911134 | Elevated preoperative platelet distribution width predicts poor prognosis in Esophageal Squamous Cell Carcinoma |
| Q37559246 | Emerging Role of Robot-assisted Gastrectomy: Analysis of Consecutive 200 Cases |
| Q37706898 | Endoscopic versus laparoscopic resection of gastric gastrointestinal stromal tumors: a multicenter study |
| Q57126039 | Enhanced Recovery after Surgery for Gastric Cancer Patients Improves Clinical Outcomes at a US Cancer Center |
| Q35562690 | Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome |
| Q35238430 | Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas |
| Q42084237 | Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer |
| Q35481147 | Evaluation of the 7th UICC TNM Staging System of Gastric Cancer |
| Q36640814 | Expression and clinical significance of Beclin-1 in gastric cancer tissues of various clinical stages |
| Q36611793 | Expression of C-X-C chemokine receptor types 1/2 in patients with gastric carcinoma: Clinicopathological correlations and significance |
| Q37714355 | Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer |
| Q57788752 | Expression of circ_001569 is upregulated in osteosarcoma and promotes cell proliferation and cisplatin resistance by activating the Wnt/β-catenin signaling pathway |
| Q54541938 | Expression of cyclophilin A in gastric adenocarcinoma patients and its inverse association with local relapses and distant metastasis. |
| Q47135872 | Extensive Lymph Node Dissection Improves Survival among American Patients with Gastric Adenocarcinoma Treated Surgically: Analysis of the National Cancer Database |
| Q97882650 | FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis |
| Q92839563 | FTL: a novel predictor in gastric cancer |
| Q93199764 | Factors Associated with Worse Outcome in Early Stage Gastric Cancer Using the Surveillance, Epidemiology, and End Results (SEER) Database |
| Q35625410 | Factors associated with early recurrence after curative surgery for gastric cancer |
| Q90477778 | Factors associated with metastasis in superior mesenteric vein lymph node in subtotal gastrectomy for gastric cancer: Retrospective case control study |
| Q50079491 | Factors influencing health-related quality of life after gastrectomy for cancer |
| Q54967237 | Feasibility of differentiating T3 from T4a gastric cancer in different Lauren classification by determining serosa invasion: Diagnostic performance of high enhanced serosa sign. |
| Q36373646 | Feasible endoscopic therapy for early gastric cancer |
| Q92358693 | Frequency and Clinical Characteristics of Unselected Korean Gastric Cancer Patients with a Germline CDH1 V832M Mutation |
| Q39766980 | Full robot-assisted gastrectomy: surgical technique and preliminary experience from a single center |
| Q92321788 | GLI1 activation by non-classical pathway integrin αvβ3/ERK1/2 maintains stem cell-like phenotype of multicellular aggregates in gastric cancer peritoneal metastasis |
| Q48328295 | Gastrectomy with Extended Lymphadenectomy: a North American Perspective |
| Q51384461 | Gastric cancer guidelines and genome differences between Japan and the west. |
| Q55506767 | Gastric cancer in Alaska Native people: A cancer health disparity. |
| Q37832985 | Gastric cancer surgery: an American perspective on the current options and standards |
| Q41820200 | Gastric cancer, nutritional status, and outcome |
| Q27692548 | Gastric cáncer: Overview |
| Q30411962 | Gastric intestinal metaplasia and early gastric cancer in the west: a changing paradigm |
| Q85001437 | Gastric tube reconstruction reduces postoperative gastroesophageal reflux in adenocarcinoma of esophagogastric junction |
| Q34630658 | Gastrointestinal stromal tumors (GISTs) of the stomach: a multicenter, retrospective study of curatively resected gastric GISTs |
| Q55333950 | Gene Expression Analysis of Two Epithelial-mesenchymal Transition-related Genes: Long Noncoding RNA-ATB and SETD8 in Gastric Cancer Tissues. |
| Q37457926 | Genetic polymorphisms in TNIP1 increase the risk of gastric carcinoma |
| Q52562700 | Genetic variants in the nucleotide excision repair pathway genes and gastric cancer susceptibility in a southern Chinese population. |
| Q45254443 | Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population |
| Q53746854 | Harvest of at Least 23 Lymph Nodes is Indispensable for Stage N3 Gastric Cancer Patients. |
| Q47863981 | Heat shock protein 70 (HSP70) expression is associated with poor prognosis in intestinal type gastric cancer |
| Q37034088 | Hepatoid adenocarcinoma of the stomach: a report of three cases |
| Q61444427 | High Expression of long non-coding RNA PVT1 predicts metastasis in Han and Uygur Patients with Gastric Cancer in Xinjiang, China |
| Q37411864 | High Hepsin expression predicts poor prognosis in Gastric Cancer |
| Q92382465 | High expression of fibronectin 1 indicates poor prognosis in gastric cancer |
| Q53546129 | Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis. |
| Q47734827 | Identification of Candidates for Early Discharge After Gastrectomy |
| Q90480845 | Identification of circulating tumor DNA using a targeted 545-gene next generation sequencing panel in patients with gastric cancer |
| Q89966178 | Identification of the Prognosis-Related lncRNAs and Genes in Gastric Cancer |
| Q93090694 | Identification of the clinically most relevant postoperative complications after gastrectomy: a population-based cohort study |
| Q40562647 | Identifying Reproducible Molecular Biomarkers for Gastric Cancer Metastasis with the Aid of Recurrence Information |
| Q41866875 | Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma. |
| Q99564954 | Immunophenotype based on inflammatory cells, PD-1/PD-L1 signalling pathway and M2 macrophages predicts survival in gastric cancer |
| Q91638661 | Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population |
| Q36464594 | Impact of chemokine receptor CXCR3 on tumor-infiltrating lymphocyte recruitment associated with favorable prognosis in advanced gastric cancer |
| Q51020295 | Impact of incidental findings on integrated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in patients with gastric cancer. |
| Q36105570 | Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer |
| Q85642862 | Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis |
| Q44662763 | Impact of obesity on early surgical and oncologic outcomes after total gastrectomy with "over-D1" lymphadenectomy for gastric cancer. |
| Q48227570 | Impact of preoperative anemia on outcomes in patients undergoing curative resection for gastric cancer: a single-institution retrospective analysis of 2163 Chinese patients |
| Q36328544 | Impact of systemic inflammation on gastric cancer outcomes |
| Q41146331 | Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010. |
| Q53455151 | Incorporating surgical quality into the AJCC 7th edition improves staging accuracy in gastric cancer. |
| Q36663831 | Increased Expression of CSF-1 Associates With Poor Prognosis of Patients With Gastric Cancer Undergoing Gastrectomy |
| Q38882545 | Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma |
| Q36334152 | Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma |
| Q36819620 | Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma |
| Q91756122 | Increased expression of methionine sulfoxide reductases B3 is associated with poor prognosis in gastric cancer |
| Q37376464 | Increased number of negative lymph nodes is associated with improved survival outcome in node positive gastric cancer following radical gastrectomy |
| Q47944019 | Intratumor stromal proportion predicts aggressive phenotype of gastric signet ring cell carcinomas. |
| Q52725329 | Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer. |
| Q59354214 | Irreversible electroporation of malignant liver tumors: Effect on laboratory values |
| Q33592400 | Is adjuvant chemotherapy necessary in pT1N1 gastric cancer? |
| Q37585316 | Is noncurative gastrectomy always a beneficial strategy for stage IV gastric cancer? |
| Q64108587 | KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study |
| Q37298707 | LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis |
| Q52605309 | LTBP2 promotes the migration and invasion of gastric cancer cells and predicts poor outcome of patients with gastric cancer. |
| Q54979500 | Label-free quantitative proteomic analysis identifies CTNNB1 as a direct target of FOXP3 in gastric cancer cells. |
| Q89966345 | Laparoscopic D2 plus complete mesogastrium excision using the "enjoyable space" approach versus conventional D2 total gastrectomy for local advanced gastric cancer: short-term outcomes |
| Q92384159 | Laparoscopic Whipple's Operation for Locally Advanced Gastric Cancer Invading the Pancreas and Duodenum: a Case Report |
| Q92229617 | Laparoscopic perigastric mesogastrium excision technique for radical total gastrectomy |
| Q34093907 | Laparoscopic spleen-preserving splenic hilar lymphadenectomy in 108 consecutive patients with upper gastric cancer |
| Q24185996 | Laparoscopic versus open gastrectomy for gastric cancer |
| Q24188239 | Laparoscopic versus open gastrectomy for gastric cancer |
| Q44123427 | Laparoscopy and peritoneal cytology: important prognostic tools to guide treatment selection in gastric adenocarcinoma |
| Q33595414 | Learning curve for gastric cancer patients with laparoscopy-assisted distal gastrectomy: 6-year experience from a single institution in western China |
| Q90325006 | Learning curve of totally laparoscopic distal gastrectomy for gastric cancer: a single teaching hospital study |
| Q34036751 | Length of negative resection margin does not affect local recurrence and survival in the patients with gastric cancer |
| Q53724691 | Lgr5High/DCLK1High phenotype is more common in early stage and intestinal subtypes of gastric carcinomas. |
| Q64064539 | Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients |
| Q91583180 | LncRNA H19 induced by helicobacter pylori infection promotes gastric cancer cell growth via enhancing NF-κB-induced inflammation |
| Q38432450 | Long non-coding RNA DANCR, a prognostic indicator, promotes cell growth and tumorigenicity in gastric cancer |
| Q89966774 | Long non-coding RNA polymorphisms on 8q24 are associated with the prognosis of gastric cancer in a Chinese population |
| Q33680872 | Long term follow up and retrospective study on 533 gastric cancer cases |
| Q55506227 | Long-Term Nutritional Outcomes of Near-Total Gastrectomy in Gastric Cancer Treatment: a Comparison with Total Gastrectomy Using Propensity Score Matching Analysis. |
| Q40091350 | Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study |
| Q47136824 | Long-term Follow-up for Type 2 Diabetes Mellitus after Gastrectomy in Non-morbidly Obese Patients with Gastric Cancer: the Legitimacy of Onco-metabolic Surgery |
| Q36373641 | Long-term outcomes after radical gastrectomy in gastric cancer patients with overt bleeding |
| Q89250583 | Long-term outcomes of laparoscopy-assisted distal gastrectomy versus open distal gastrectomy for gastric cancer: a 10-year single-institution experience |
| Q37437526 | Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer |
| Q64922740 | Low Preoperative Lymphocyte to Monocyte Ratio Serves as a Worse Prognostic Marker in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Tumor Resection. |
| Q36806696 | Low Serum Albumin Level, Male Sex, and Total Gastrectomy Are Risk Factors of Severe Postoperative Complications in Elderly Gastric Cancer Patients |
| Q43956620 | Low prevalence of microsatellite instability in interval gastric cancers. |
| Q37325956 | Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases |
| Q38794208 | Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes |
| Q40407857 | Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study |
| Q38992258 | MDCT imaging of the stomach: advances and applications. |
| Q40714671 | MDCT in the preoperative staging of gastric adenocarcinoma |
| Q37376407 | MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect |
| Q91451119 | MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer |
| Q38157342 | Management of gastric cancer in Asia: resource-stratified guidelines |
| Q37465651 | Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery |
| Q37370177 | Mast Cells Positive to Tryptase and c-Kit Receptor Expressing Cells Correlates with Angiogenesis in Gastric Cancer Patients Surgically Treated |
| Q44662323 | Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically |
| Q47710948 | Measurement of tumor volume is not superior to diameter for prediction of lymph node metastasis in early gastric cancer with minute submucosal invasion. |
| Q34294000 | Mechanisms of GOLPH3 associated with the progression of gastric cancer: a preliminary study |
| Q55012312 | Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer. |
| Q38728171 | MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA |
| Q52649732 | MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression. |
| Q42682692 | MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer. |
| Q37743005 | Minimally invasive surgery for gastric cancer: A comparison between robotic, laparoscopic and open surgery. |
| Q85274258 | Mitochondrial DNA haplogroup N is associated good outcome of gastric cancer |
| Q49386978 | Modified vs. standard D2 lymphadenectomy in distal subtotal gastrectomy for locally advanced gastric cancer patients under 70 years of age. |
| Q34750564 | Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patients |
| Q37516412 | Monitoring of peri-distal gastrectomy carbohydrate antigen 19-9 level in gastric juice and its significance |
| Q38598951 | Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy |
| Q42378441 | Natural killer cell activity for IFN-gamma production as a supportive diagnostic marker for gastric cancer |
| Q57213645 | Nature versus nurture: the impact of nativity and site of treatment on survival for gastric cancer |
| Q26738548 | New advances in targeted gastric cancer treatment |
| Q61443528 | New metastatic lymph node classification for early gastric cancer should differ from those for advanced gastric adenocarcinoma: Results based on the SEER database |
| Q60917771 | Nodal staging score and adequacy of nodal staging |
| Q34867750 | Occurrence of Helicobacter pylori and Epstein-Barr virus infection in endoscopic and gastric cancer patients from Northern Brazil |
| Q42649468 | Oncologic outcomes of laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective cohort study from China |
| Q40813958 | Open vs robotic radical gastrectomy for locally advanced gastric cancer |
| Q55237429 | Optimal Endoscopic Screening Interval for Early Detection of Gastric Cancer: a Single-Center Study. |
| Q90685643 | Outcomes after completion total gastrectomy for gastric remnant cancer: experience from a Canadian tertiary centre |
| Q64061283 | Outcomes of gastrectomy following upfront chemotherapy in advanced gastric cancer patients with a single noncurable factor: a cohort study |
| Q41452357 | Overall Survival Is Impacted by Birthplace and Not Extent of Surgery in Asian Americans with Resectable Gastric Cancer |
| Q92715734 | Overexpression of FAM3C protein as a novel biomarker for epithelial-mesenchymal transition and poor outcome in gastric cancer |
| Q47104012 | Overexpression of HS6ST2 is associated with poor prognosis in patients with gastric cancer |
| Q55063359 | Overexpression of MYC binding protein promotes invasion and migration in gastric cancer. |
| Q35202594 | Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer |
| Q89763232 | P2X7R as an independent prognostic indicator in gastric cancer |
| Q60922878 | PIK3CA Mutation Analysis in Iranian Patients with Gastric Cancer |
| Q37735594 | Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer |
| Q50071329 | Pathologic Features of Esophageal and Gastric Malignancies. |
| Q40393475 | Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer |
| Q64250229 | Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy |
| Q33714143 | Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy |
| Q33645959 | Peritoneal lavage examination as a prognostic tool in cases of gastric cancer |
| Q41396108 | Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with Gastric Cancer |
| Q64327586 | Pilot Study: Detection of Gastric Cancer From Exhaled Air Analyzed With an Electronic Nose in Chinese Patients |
| Q54185346 | Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. |
| Q34482197 | Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population |
| Q37249007 | Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population |
| Q36760391 | Polymorphisms of the DNA Methyltransferase 1 Gene Predict Survival of Gastric Cancer Patients Receiving Tumorectomy |
| Q93110004 | Postoperative Monocyte Count Change Is a Better Predictor of Survival Than Preoperative Monocyte Count in Esophageal Squamous Cell Carcinoma |
| Q34962091 | Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy. |
| Q91906443 | Postoperative morbidity and mortality after neoadjuvant chemotherapy versus upfront surgery for locally advanced gastric cancer: a propensity score matching analysis |
| Q92985444 | Practicality and short-term outcomes of intracorporeal gastroduodenostomy in totally laparoscopic distal gastrectomy for gastric cancer: A single-centre retrospective study |
| Q94592983 | Predictive Factors for Lymph Node Metastasis and the Effect on Survival in Early Gastric Cancer Patients with Radical Gastric Resection |
| Q86191276 | Predictors of Lymph Node Metastasis in Western Early Gastric Cancer |
| Q85216117 | Predictors of lymph node metastasis in patients with non-curative endoscopic resection of early gastric cancer |
| Q47647177 | Preoperative Body Mass Index May Determine the Prognosis of Advanced Gastric Cancer |
| Q36053971 | Preoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer |
| Q43143206 | Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer |
| Q57126061 | Preoperative Nodal F-FDG Avidity Rather than Primary Tumor Avidity Determines the Prognosis of Patients with Advanced Gastric Cancer |
| Q37367263 | Preoperative Nutritional Deficiency Is a Useful Predictor of Postoperative Outcome in Patients Undergoing Curative Resection for Gastric Cancer |
| Q35833318 | Preoperative Quality of Life in Patients with Gastric Cancer |
| Q57807462 | Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study |
| Q88997602 | Preoperative monocyte-lymphocyte and neutrophil-lymphocyte but not platelet-lymphocyte ratios are predictive of clinical outcomes in resected patients with non-metastatic Siewert type II/III adenocarcinoma of esophagogastric junction: a prospective |
| Q37035451 | Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer |
| Q37391008 | Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction |
| Q90352586 | Preoperative prealbumin levels on admission as an independent predictive factor in patients with gastric cancer |
| Q37706864 | Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients |
| Q33669818 | Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer |
| Q39174248 | Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence |
| Q42378389 | Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients. |
| Q37634947 | Prognostic Discrepancy of the 6th and 7th UICC N Classification for Lymph Node Staging in Gastric Cancer Patients after Curative Resection |
| Q64237809 | Prognostic Factors and Recurrence Patterns in T4 Gastric Cancer Patients after Curative Resection |
| Q41472506 | Prognostic Factors for Node-Negative Advanced Gastric Cancer after Curative Gastrectomy |
| Q36531823 | Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy |
| Q43373052 | Prognostic Significance of Preoperative and Postoperative Complement C3 Depletion in Gastric Cancer: A Three-Year Survival Investigation. |
| Q37328391 | Prognostic Significance of Tumor Size in 2405 Patients With Gastric Cancer: A Retrospective Cohort Study |
| Q36838041 | Prognostic Value of Lymph Node Ratio in Patients Receiving Combined Surgical Resection for Gastric Cancer Liver Metastasis: Results from Two National Centers in China |
| Q50055280 | Prognostic Value of the Expression of DNA Repair-Related Biomarkers Mediated by Alcohol in Gastric Cancer Patients |
| Q36070010 | Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review |
| Q39094562 | Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario. |
| Q42292848 | Prognostic implication of hepatoduodenal ligament lymph nodes in gastric cancer |
| Q36089994 | Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer |
| Q37402113 | Prognostic potential of an immune score based on the density of CD8+ T cells, CD20+ B cells, and CD33+/p-STAT1+ double-positive cells and HMGB1 expression within cancer nests in stage IIIA gastric cancer patients |
| Q53104826 | Prognostic significance of CEA expression by RT-PCR in peritoneal wash from patients with gastric cancer: result of a 5-year follow-up after curative resection. |
| Q33827385 | Prognostic significance of ERCC1 expression in postoperative patients with gastric cancer |
| Q36316680 | Prognostic significance of distal subtotal gastrectomy with standard D2 and extended D2 lymphadenectomy for locally advanced gastric cancer |
| Q55404843 | Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer. |
| Q46474653 | Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer. |
| Q46169177 | Prognostic significance of peritoneal lavage cytology in patients with colorectal cancer. |
| Q90485705 | Prognostic significance of poorly cohesive gastric carcinoma in Tunisian patients |
| Q49256839 | Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study |
| Q38613676 | Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients. |
| Q36464803 | Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy |
| Q38633179 | Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection |
| Q43112900 | Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer |
| Q50352443 | Prognostic value of fibrosis ratio in metastatic lymph nodes of node-positive advanced gastric cancer |
| Q36193362 | Prognostic value of genetic detection using CEA and MAGE in peritoneal washes with gastric carcinoma after curative resection: result of a 3-year follow-up |
| Q35128731 | Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model |
| Q42290661 | Prognostic value of pretreatment albumin-globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection |
| Q49283933 | Prognostic value of resected lymph nodes numbers for Siewert II gastroesophageal junction cancer |
| Q92715460 | Prognostic value of transducer of ErbB2.1 (TOB1) expression in patients with gastric cancer: tissue microarray analysis |
| Q52647701 | Prognostic value of tripartite motif containing 29 expression in patients with gastric cancer following surgical resection. |
| Q33690194 | Prohibitin expression deregulation in gastric cancer is associated with the 3' untranslated region 1630 C>T polymorphism and copy number variation |
| Q48626617 | Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer. |
| Q39982270 | Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project |
| Q43698446 | Proposal of the surgical options for primary tumor control during sentinel node navigation surgery based on the discrepancy between preoperative and postoperative early gastric cancer diagnoses. |
| Q37176345 | Prospective Multicenter Feasibility Study of Laparoscopic Sentinel Basin Dissection for Organ Preserving Surgery in Gastric Cancer: Quality Control Study for Surgical Standardization Prior to Phase III Trial |
| Q38200031 | Prospective comparison of 3T MRI with diffusion-weighted imaging and MDCT for the preoperative TNM staging of gastric cancer |
| Q35775970 | Quantification of the Iodine Content of Perigastric Adipose Tissue by Dual-Energy CT: A Novel Method for Preoperative Diagnosis of T4-Stage Gastric Cancer |
| Q34207957 | Rare cause of upper gastrointestinal bleeding owing to hepatic cancer invasion: a case report |
| Q43246119 | Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2'-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells |
| Q35963781 | Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer |
| Q36782319 | Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression |
| Q36540105 | Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis |
| Q30693808 | Reference genes for quantitative RT-PCR data in gastric tissues and cell lines |
| Q28067269 | Regional but fatal: Intraperitoneal metastasis in gastric cancer |
| Q37152887 | Regional variation in the management of metastatic gastric cancer in Ontario. |
| Q46321211 | Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics |
| Q64079593 | Regulatory T Cells and Plasmacytoid Dendritic Cells Within the Tumor Microenvironment in Gastric Cancer Are Correlated With Gastric Microbiota Dysbiosis: A Preliminary Study |
| Q41420061 | Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosae |
| Q36784921 | Relationship between low body mass index and morbidity after gastrectomy for gastric cancer |
| Q90098565 | Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis |
| Q47312073 | Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis |
| Q50125040 | Right-Side Approach-Duet Totally Laparoscopic Distal Gastrectomy (R-Duet TLDG) Using a Three-Port to Treat Gastric Cancer |
| Q40612447 | Risk Factors for Lymph Node Metastasis in Early Gastric Cancer with Signet Ring Cell Carcinoma |
| Q56619682 | Risk Factors for Postoperative Delirium After Gastrectomy in Gastric Cancer Patients |
| Q38958572 | Risk factors affecting unplanned reoperation after laparoscopic gastrectomy for gastric cancer: experience from a high-volume center |
| Q51194118 | Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: a case-control study. |
| Q37225868 | Robotic Total Gastrectomy With Intracorporeal Robot-Sewn Anastomosis: A Novel Approach Adopting the Double-Loop Reconstruction Method |
| Q38335914 | Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy. |
| Q36180036 | Robotic, laparoscopic and open surgery for gastric cancer compared on surgical, clinical and oncological outcomes: a multi-institutional chart review. A study protocol of the International study group on Minimally Invasive surgery for GASTRIc Cancer |
| Q37724715 | Role of 3DCT in laparoscopic total gastrectomy with spleen-preserving splenic lymph node dissection |
| Q26753850 | Role of genetic detection in peritoneal washes with gastric carcinoma: The past, present and future |
| Q57283032 | Role of serum EBV-VCA IgG detection in assessing gastric cancer risk and prognosis in Northern Chinese population |
| Q38958484 | Routine Radiologic Contrast Agent Examination After Gastrectomy for Gastric Cancer Is Not Useful |
| Q90447849 | SE translocation gene but not zinc finger or X-linked factor is down-regulated in gastric cancer |
| Q38787554 | SOX2 inhibits metastasis in gastric cancer |
| Q41508242 | Safety and feasibility of minimally invasive gastrectomy during the early introduction in the Netherlands: short-term oncological outcomes comparable to open gastrectomy. |
| Q55093055 | Safety of Laparoscopic Sentinel Basin Dissection in Patients with Gastric Cancer: an Analysis from the SENORITA Prospective Multicenter Quality Control Trial. |
| Q57126018 | Sarcopenia and Post-Operative Morbidity and Mortality in Patients with Gastric Cancer |
| Q38782022 | Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patients |
| Q50719245 | Semi-end-to-end esophagojejunostomy after laparoscopy-assisted total gastrectomy better reduces stricture and leakage than the conventional end-to-side procedure: A retrospective study. |
| Q42094686 | Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy |
| Q44776136 | Serum VEGF and VEGF-C values before surgery and after postoperative treatment in gastric cancer. |
| Q36858170 | Serum biomarker panels for diagnosis of gastric cancer |
| Q44075043 | Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement? |
| Q33587177 | Short-term surgical outcomes of laparoscopy-assisted versus totally laparoscopic Billroth-II gastrectomy for gastric cancer: a matched-cohort study |
| Q50634903 | Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer. |
| Q57176429 | Significance of Preoperative Systemic Immune Score for Stage I Gastric Cancer Patients |
| Q35651537 | Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer |
| Q41472554 | Single-Port Laparoscopic Proximal Gastrectomy with Double Tract Reconstruction for Early Gastric Cancer: Report of a Case. |
| Q35128212 | Small-volume chylous ascites after laparoscopic radical gastrectomy for gastric cancer: results from a large population-based sample |
| Q92390496 | Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment |
| Q37724651 | State-of-the-art preoperative staging of gastric cancer by MDCT and magnetic resonance imaging |
| Q90553405 | Superiority of Tumor Location-Modified Lauren Classification System for Gastric Cancer: A Multi-Institutional Validation Analysis |
| Q37588241 | Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center |
| Q38016802 | Surgical approaches to gastric cancer |
| Q35742852 | Surgical considerations in the treatment of gastric cancer |
| Q59806717 | Surgical treatment of gastric cancer: a 10-year experience in a high-volume university hospital |
| Q57071075 | Survival and prognosis of young adults with gastric cancer |
| Q47980466 | Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy |
| Q90336188 | Survival outcomes after D1 and D2 lymphadenectomy with R0 resection in stage II-III gastric cancer: Longitudinal follow-up in a single center |
| Q40528589 | Survival rates in T1 and T2 gastric cancer: A Western report. |
| Q55472607 | TIMP2 is a Poor Prognostic Factor and Predicts Metastatic Biological Behavior in Gastric Cancer. |
| Q57125951 | The Impact of Preoperative Low Body Mass Index on Postoperative Complications and Long-term Survival Outcomes in Gastric Cancer Patients |
| Q92669638 | The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer |
| Q89967122 | The Methods of Lymph Node Examination Make a Difference to Node Staging and Detection of N3b Node Status for Gastric Cancer |
| Q44228863 | The Multidisciplinary Team Conference's Decision on M-Staging in Patients with Gastric- and Gastroesophageal Cancer is not Accurate without Staging Laparoscopy |
| Q41113312 | The Prognostic Nutritional Index Predicts Survival and Identifies Aggressiveness of Gastric Cancer |
| Q37549192 | The Ratio-Based N Staging System Can More Accurately Reflect the Prognosis of T4 Gastric Cancer Patients with D2 Lymphadenectomy Compared with the 7th American Joint Committee on Cancer/Union for International Cancer Control Staging System |
| Q64103841 | The Significant Influence of the Neuroendocrine Component on the Survival of Patients with Gastric Carcinoma Characterized by Coexisting Exocrine and Neuroendocrine Components |
| Q36759903 | The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer |
| Q37641553 | The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines. |
| Q38734914 | The comprehensive complication index (CCI) is a more sensitive complication index than the conventional Clavien-Dindo classification in radical gastric cancer surgery |
| Q36221083 | The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer |
| Q44108051 | The evaluation of surgical treatment for gastric cancer patients with noncurative resection |
| Q40962026 | The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality |
| Q92495157 | The incidence and risk factors for surgical site infection in older adults after gastric cancer surgery: A STROBE-compliant retrospective study |
| Q33618344 | The influence of marital status on the stage at diagnosis, treatment, and survival of adult patients with gastric cancer: a population-based study |
| Q52671366 | The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1. |
| Q92085892 | The optimal extent of lymph node dissection in gastroesophageal junctional cancer: retrospective case control study |
| Q36083589 | The predictors and clinical impact of positive resection margins on frozen section in gastric cancer surgery |
| Q50105819 | The prognosis role of AJCC/UICC 8th edition staging system in gastric cancer, a retrospective analysis |
| Q55370387 | The prognostic value of age in non-metastatic gastric cancer after gastrectomy: a retrospective study in the U.S. and China. |
| Q41996520 | The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up |
| Q42031892 | The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction |
| Q47153449 | The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer |
| Q57223849 | The risk factors for lymph node metastasis in early gastric cancer patients who underwent endoscopic resection: is the minimal lymph node dissection applicable? A retrospective study |
| Q38817938 | The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review |
| Q98288379 | The value of multidetector-row computed tomography in lymph node staging of gastric cancer: a preliminary Vietnamese study |
| Q57211237 | Three-year interval for endoscopic screening may reduce the mortality in patients with gastric cancer |
| Q38119975 | Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review |
| Q37418756 | Totally laparoscopic versus laparoscopy-assisted Billroth-I anastomosis for gastric cancer: a case-control and case-matched study |
| Q34137285 | Towards personalized perioperative treatment for advanced gastric cancer. |
| Q38876823 | Treatment patterns in patients with advanced gastric cancer in Taiwan |
| Q33605559 | Tryptase mast cell density, protease-activated receptor-2 microvascular density, and classical microvascular density evaluation in gastric cancer patients undergoing surgery: possible translational relevance |
| Q41862770 | Tumor size as a prognostic factor in gastric cancer patient |
| Q36316738 | Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach |
| Q39093050 | Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway |
| Q37745896 | Tumor volume increases the predictive accuracy of prognosis for gastric cancer: A retrospective cohort study of 3409 patients |
| Q52591880 | Tumor-Associated Macrophages and Mast Cells Positive to Tryptase Are Correlated with Angiogenesis in Surgically-Treated Gastric Cancer Patients. |
| Q90106921 | Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer |
| Q93140715 | Tumor‑suppressive miR‑299‑3p inhibits gastric cancer cell invasion by targeting heparanase |
| Q102220423 | UFBP1, a key component in ufmylation, enhances drug sensitivity by promoting proteasomal degradation of oxidative stress-response transcription factor Nrf2 |
| Q34867119 | Uncut Roux-en-Y Reconstruction after Laparoscopic Distal Gastrectomy Can Be a Favorable Method in Terms of Gastritis, Bile Reflux, and Gastric Residue |
| Q92520846 | Upper Endoscopy up to 3 Years Prior to a Diagnosis of Gastric Cancer Is Associated With Lower Stage of Disease in a USA Multiethnic Urban Population, a Retrospective Study |
| Q38696668 | Upregulation of long non-coding RNA DQ786243 promotes the progression of gastric cancer |
| Q46132640 | VEGF-A and VEGF-B mRNA expression in gastro-oesophageal cancers |
| Q47998821 | Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database. |
| Q50100162 | Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis |
| Q37942517 | Validation of the updated 7th edition AJCC TNM staging criteria for gastric adenocarcinoma |
| Q36238866 | Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study |
| Q33623988 | Weekday of Surgery Affects Postoperative Complications and Long-Term Survival of Chinese Gastric Cancer Patients after Curative Gastrectomy. |
| Q33863662 | Which Factors Are Important for Successful Sentinel Node Navigation Surgery in Gastric Cancer Patients? Analysis from the SENORITA Prospective Multicenter Feasibility Quality Control Trial. |
| Q37709154 | YWHAE silencing induces cell proliferation, invasion and migration through the up-regulation of CDC25B and MYC in gastric cancer cells: new insights about YWHAE role in the tumor development and metastasis process |
| Q33706171 | miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression |
Search more.